Satu Mustjoki (MD, PhD)
Hematology Research Unit Helsinki, Translational Immunology research Program, University of Helsinki, Finland
Dr. Satu Mustjoki, MD, PhD is a professor of Translational Hematology at the University of Helsinki, Finland. She received her medical degree (1997) and PhD degree (2001) at the University of Helsinki, after which she did her specialty degree in Clinical Chemistry (laboratory hematology).
Satu Mustjoki started her own research group in 2008 at the Helsinki University Hospital, and her research experience includes basic and applied cancer research on leukemia and hematopoietic stem cells, cancer cell invasion, tumor immunology, and molecular genetics. She has also led several translational immunological biomarker studies in conjunction with the international clinical trials in leukemia. Her current research interests focus both on tumor immunology and on the molecular mechanisms of T-cell malignancies and associated autoimmune disorders.
Currently Satu Mustjoki is leading the Translational Immunology Research Program at the Faculty of Medicine, University of Helsinki, Finland (www.helsinki.fi/trimm). Her own research group at the Hematology Research Unit Helsinki (www.helsinki.fi/hematology) consists of 24 members involving both basic and clinical scientists in hematology and immunology. In 2015 she received a 5-year European Research Council (ERC) Consolidator Grant, which relates to molecular mechanisms of autoimmune disorders. Satu Mustjoki has more than 120 publications in international peer reviewed journals, such as New England Journal of Medicine, Nature Genetics, Nature Communications, Blood, and Leukemia.
- Cancer research on leukemia and hematopoietic stem cells
- Cancer cell invasion
- Tumor immunology
- Molecular genetics
- Molecular mechanisms of T-cell malignancies and associated autoimmune disorders
Department of Clinical Chemistry and Hematology
University of Helsinki
Helsinki, Finland, 00290